Shuttle Pharmaceuticals Stock Alpha and Beta Analysis
| SHPH Stock | USD 0.90 0.01 1.12% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Shuttle Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in Shuttle Pharmaceuticals over a specified time horizon. Remember, high Shuttle Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Shuttle Pharmaceuticals' market risk premium analysis include:
Beta (2.30) | Alpha (0.65) | Risk 8.3 | Sharpe Ratio (0.15) | Expected Return (1.26) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Shuttle |
Shuttle Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Shuttle Pharmaceuticals market risk premium is the additional return an investor will receive from holding Shuttle Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Shuttle Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Shuttle Pharmaceuticals' performance over market.| α | -0.65 | β | -2.3 |
Shuttle Pharmaceuticals expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Shuttle Pharmaceuticals' Buy-and-hold return. Our buy-and-hold chart shows how Shuttle Pharmaceuticals performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Shuttle Pharmaceuticals Market Price Analysis
Market price analysis indicators help investors to evaluate how Shuttle Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Shuttle Pharmaceuticals shares will generate the highest return on investment. By understating and applying Shuttle Pharmaceuticals stock market price indicators, traders can identify Shuttle Pharmaceuticals position entry and exit signals to maximize returns.
Shuttle Pharmaceuticals Return and Market Media
The median price of Shuttle Pharmaceuticals for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 1.35 with a coefficient of variation of 26.44. The daily time series for the period is distributed with a sample standard deviation of 0.39, arithmetic mean of 1.47, and mean deviation of 0.32. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Shuttle Pharma Provides Second Quarter 2024 Corporate Update | 09/04/2024 |
2 | Disposition of 8372 shares by Dritschilo Anatoly of Shuttle Pharmaceuticals at 1.605 subject to Rule 16b-3 | 09/13/2024 |
3 | Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma | 09/16/2024 |
4 | Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma | 10/28/2024 |
5 | Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of 4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules | 10/30/2024 |
6 | Shuttle Pharma Provides Third Quarter 2024 Corporate Update | 11/13/2024 |
About Shuttle Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Shuttle or other stocks. Alpha measures the amount that position in Shuttle Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Shuttle Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of Shuttle Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shuttle Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Shuttle Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Shuttle Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Shuttle Pharmaceuticals' management manipulating its earnings.
| 20th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Shuttle Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Shuttle Pharmaceuticals Backtesting, Shuttle Pharmaceuticals Valuation, Shuttle Pharmaceuticals Correlation, Shuttle Pharmaceuticals Hype Analysis, Shuttle Pharmaceuticals Volatility, Shuttle Pharmaceuticals History and analyze Shuttle Pharmaceuticals Performance. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Shuttle Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.